Mission „Krebs besiegen“

1. We want to better understand cancer
   Modern research approaches view cancer treatment through the lens of its molecular and cellular foundations. The new research platform UNCAN.eu will consolidate molecular medicine data and make it accessible to all major cancer research institutions in Austria. This will deepen our understanding of cancer at the molecular level and pave the way for new treatment methods.

    

2. We want to detect cancer earlier
   The earlier cancer is detected, the higher the chances of recovery. In Austria, an organized and quality-assured early detection program for breast cancer has already been successfully implemented. Within the framework of the Mission „Krebs besiegen“, steps will also be taken toward establishing a national colorectal cancer screening program, and options for improving early detection of lung cancer in high-risk patients will be explored — to identify and treat such diseases at the earliest possible stage.

    

3. We want to strengthen the networking of our leading cancer centers
   Worldwide, Comprehensive Cancer Centres play a key role in advancing research and improving medical treatment for cancer. Austria is home to several of these highly specialized centers in Vienna, Graz, Innsbruck, Salzburg, and Linz. To further enhance collaboration in care, research, and communication, the activities and expertise of these centers will be more closely interconnected.

    

4. We want to establish a clinical cancer registry
   Austria aims to develop the foundation for a comprehensive national clinical cancer registry covering dozens of oncological areas and incorporating reports and experiences from affected patients. A dedicated cancer registry study and research program will determine which data on which tumor types should be collected uniformly across the country.

5. We want to improve long-term follow-up care for young cancer survivors
   For children and adolescents who have survived cancer, a “Survivorship Passport” will be introduced. This document will contain key medical data that can be accessed when needed — for example, in case of recurrence, the onset of another illness, or when planning a family later in life.

    

6. We advocate for national co-financing programs
   To enable Austrian institutions and companies to access European funds within the framework of the Mission „Krebs besiegen“, national co-financing for projects is essential. The Krebs besiegen working group advocates for the establishment and proper funding of these programs.

A central principle of Austria’s Mission „Krebs besiegen“ is to integrate the perspective of the population into research from the very beginning. This includes prevention, early detection, treatment, and care. We invite you to join us in advancing the Mission „Krebs besiegen“ together!

At the European level, numerous projects — including several with Austrian participation — are continuously being funded. These can be found on the European Cancer Mission Implementation Platform. Are you interested in contributing to European Mission projects? Contact the FFG experts responsible for the respective European Missions.

Our Call to Action is addressed to research institutions and organizations in the healthcare sector, as well as to interested and affected individuals.

Even the longest journey begins with a single step. We have defined the goals for the Mission, and now implementation will proceed step by step. This process requires the collective effort of many.

Write to us or give us a call! We would be happy to explore opportunities for collaboration and include you in our network.

• Arbeitsgemeinschaft hämato-onkologischer Pflegepersonen in Österreich (AHOP)
• Austrian Group for Medical Tumor Therapy
• Austrian Institute of Technology (AIT)
• AWS
• Boehringer Ingelheim
• Bundesministerium für Frauen, Wissenschaft und Forschung (BMFWF)
• Bundesministerium für Soziales, Gesundheit, Pflege und Konsumentenschutz (BMASGPK)
• Cancer Cluster Salzburg, Universität Salzburg; Fachbereich Biowissenschaften & Medizinische Biologie (PLUS)
• Cancer Research Institute Salzburg
• CCI Europe Committee, Childhood Cancer International – Europe
• CEMM Forschungszentrum für molekulare Medizin, Medizinische Universität Wien (MUW)
• Die Allianz onkologischer PatientInnenorganisationen
• Österreichische Forschungsförderungsgesellschaft (FFG)
• FH Technikum Wien
• Fonds zur Förderung der wissenschaftlichen Forschung (FWF)
• Forschungsinstitut für molekulare Pathologie (IMP)
• Gesundheit Österreich GmbH (GOEG)
• Hospiz Österreich
• III. Medizinische Univ.-Klinik Salzburg
• Paracelsus Medizinische Privatuniversität Salzburg
• IMC Krems
• Joanneum Research
• LKH Universitätsklinikum Graz
• Ludwig Boltzmann Gesellschaft
• Medizinische Universität Graz (MUG)
• Medizinische Universität Innsbruck (MUI)
• Medizinische Universität Wien (MUW)
• Ordensklinikum Linz
• Österreichische Gesundheitskasse (ÖGK)
• Pharmig, Verband der pharmazeutischen Industrie Österreichs
• Pro Rare Austria
• St. Anna Kinderspital
• Technische Universität Wien (TU Wien)
• UMIT Tirol
• Universität Innsbruck
• Universität Salzburg
• Universität Wien
• Verein für Darmkrebsinformation
• Verein InfluCancer
• Verein NF Kinder
• Wiener Gesundheitsverbund
• Onkologie-Beirat
• Nationales Screening Komitee auf Krebserkrankungen (NSK)